The principal goal of this project is to develop a panel of immunologic reagents directed against inositol phospholipid (InsPL)-specific phospholipase C (PLC). This goal includes the characterization of their reactivity, specificity, and their effect in functional assays. A secondary objective is the utilization of these reagents in investigating the mechanism of T lymphocyte activation. Signal transduction by several receptor, including muscarinic receptors, certain growth factor receptors, and the antigen receptors of B and T lymphocytes, is mediated, at least in part, by the products of hydrolysis of InsPL by PLC. The regulation of this enzymatic activity is crucial to controlling a cell's response. To better characterize the role of this enzymes in immune cells and attempt in depth analysis of PLC regulation, including reconstitution studies, a new generation of highly specific reagents need to be produced. Based on the deduced amino acid sequences of the various PLC isozymes and a careful analysis of their homology, we propose the synthesis of a set of peptides which will be used as Ag for the generation of antisera and MoAb. In addition, the synthetic peptides, which are tailored to regions with a high degree of probability of being involved in regulatory functions, may also be used as probes to investigate PLC regulation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC002011-02
Application #
3811106
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code